Our overall strategy is to leverage our expertise and capabilities to drive market share in Canada and internationally in order to achieve profitable growth and build sustainable, longterm shareholder value. We are focused on maximizing growth in net sales, profitability and managing cash flow in our identified core markets in Canada, Germany and Latin America. In order to ensure the longterm sustainable growth of our Company, we continue to drive category leadership and assess growth opportunities with the introduction of innovative new products, increase our market share, maintain a strong financial position and manage our cost of goods and expenses with a focus on being the lowcost, highquality producer.
Within Canada, Aphria is focused on gaining market share in the Canadian cannabis industry by executing on our strategic priorities through entering new product categories that possess the most consumer demand, while leveraging our expertise to develop brands that are truly differentiated from our competitors and optimizing our production to continue to be the highquality, lowcost producer we are today. Internationally, we are focused on business activities that provide a return on investment in the near term without being capital intensive. We intend to continue to maximize the utilization of our existing assets and investments in connection with the development and execution of our growth plans, while leveraging our cannabis expertise and wellestablished Aphria medical brand. By building on this foundation, we strive to take a leadership position in the industry.